MitoPath is a biotech start-up with the exclusive goal of bringing this potential therapeutic approach to the clinic. Our team's cumulative experience tells us that, given the incidence of 20 - 40 new cases per year in the US and Europe, this opportunity does not meet the criteria of many life science investors. However, given the maturity of the research results and anecdotal clinical evidence, we are highly motivated to advance this opportunity through investors or strategic partners with access to manufacturing and/or regulatory capabilities and expertise to complete our immediate next steps: GLP manufacturing and completion of the toxicology studies. If you would like to learn more about this opportunity, please connect with us. We would be delighted to share with you our excitement and development strategy.
| Website | http://www.mitopath.com |
| Revenue | $1 million |
| Employees | View employees |
| Address | 1576 Sweet Home Rd, Amherst, New York 14228, US |
| Industry | Biotechnology Research, Internet Service Providers, Website Hosting & Internet-Related Services, Telecommunications |
| Competitors | Duke University Health System, Cellular Dynamics International, Elysium Health, Rejuvenate Bio, Mito Health, Lifespan Research Institute, Geroscience (view competitors) |
| SIC | SIC Code 73 Companies, SIC Code 738 Companies |
| NAICS | NAICS Code 56 Companies, NAICS Code 561 Companies |
Looking for a particular MitoPath employee's phone or email?
MitoPath Questions
The MitoPath annual revenue was $1 million in 2026.
MitoPath is based in Amherst, New York.
The NAICS codes for MitoPath are [56, 561].
The SIC codes for MitoPath are [73, 738].
Related Companies
